Industry Education Sessions

Pharmacogenomics for AMP Tier 1 target coverage using Novel Nanofluidic qPCR Methodology

This industry education session will focus on cutting-edge advancements in pharmacogenomics (PGx), emphasizing the utilization of nanoscale genomics to achieve comprehensive coverage of Association for Molecular Pathology (AMP) Tier 1 targets across a range of therapeutic areas. Naveen Ramalingam, PhD, Senior Director of R&D at Standard BioTools, will present on the revolutionary application of nanofluidic qPCR technology, while Katherine Aitchison, BM BCh, PhD, FRCPsych, Professor (Departments of Psychiatry & Medical Genetics, College of Health Sciences, University of Alberta), will present preliminary results from a beta testing site, including target coverage implications for neuropsychiatric disorders.

Full coverage of Tier 1 Variants for Pharmacogenomics Studies

Wednesday, November 6 | 2:30 – 4:30pm | Poster #7022W
Presenter: Naveen Ramalingam

This poster presents a robust, automated qPCR-based workflow that successfully integrates SNP and CNV analyses, ensuring full coverage of Tier 1 variants recommended by the AMP. This approach streamlines genetic testing and enhances the accuracy and applicability of PGx testing in clinical settings, potentially improving patient outcomes through more precise and personalized medicine.